What is amisulpride?

What is Amisulpride?

Amisulpride is a selective dopamine D2/D3 receptor antagonist antipsychotic medication used primarily for treating schizophrenia, with unique dose-dependent properties: low doses (50-300 mg/day) preferentially block presynaptic receptors to treat negative symptoms, while higher doses (400-1200 mg/day) block postsynaptic receptors in the limbic system to treat positive symptoms. 1

Mechanism of Action

Amisulpride works through selective dopamine receptor antagonism with a distinctive pharmacological profile 2, 3:

• Selective D2/D3 receptor blockade - Unlike other antipsychotics, it has no appreciable affinity for serotonin, histamine, or muscarinic receptors 1
• Dose-dependent dual action:
  • At low doses (<300 mg/day): Preferentially blocks presynaptic D2/D3 autoreceptors, enhancing dopamine transmission in the frontal cortex to improve negative symptoms 2, 4
  • At higher doses (400-1200 mg/day): Blocks postsynaptic D2/D3 receptors preferentially in limbic regions rather than striatum, reducing positive symptoms while minimizing extrapyramidal side effects 5, 3

Clinical Indications

According to the most recent 2025 international guidelines 6:

For Schizophrenia Treatment:

• Second-line treatment for positive symptoms after D2 partial agonist failure (along with risperidone, paliperidone, or olanzapine) 6
• Clozapine augmentation when significant positive symptoms persist despite therapeutic clozapine levels 6
• Primary treatment for predominant negative symptoms at low doses (50 mg twice daily) when positive symptoms are well-controlled 6

Additional Uses:

• Treatment of depressive symptoms in schizophrenia 2, 5
• Management of impulsive/disruptive behaviors in adolescents 7
• FDA-approved as BARHEMSYS for prevention and treatment of postoperative nausea and vomiting (5-10 mg IV) 1

Dosing Strategy

For acute schizophrenia with positive symptoms: Start 400-800 mg/day, may increase up to 1200 mg/day 8, 5

For predominant negative symptoms: Use 50-300 mg/day (e.g., 50 mg twice daily) 6, 5

For clozapine augmentation: Add 200-800 mg/day to existing clozapine regimen 8

Advantages Over Other Antipsychotics

Amisulpride demonstrates several clinically meaningful benefits 8, 2, 5:

• Superior efficacy for negative symptoms - The only antipsychotic proven effective specifically for predominantly negative symptoms 2, 5
• Better tolerability profile:
  • Significantly fewer extrapyramidal symptoms than haloperidol or flupenthixol 5
  • Less weight gain than olanzapine and risperidone 8
  • Does not increase body mass index 8
  • Favorable lipid profile effects 8
  • Minimal anticholinergic burden (unlike clozapine, olanzapine, quetiapine) 6
• Low drug interaction potential - Not metabolized by cytochrome P450 enzymes 1, 9
• Improved quality of life and social functioning compared to typical antipsychotics 2, 5

Important Caveats and Monitoring

Key Side Effects:

• Prolactin elevation - The primary endocrine concern; may increase maternal milk production 1, 9
• QT prolongation - Dose-dependent; maximum mean ΔΔQTcF of 23.4 ms at supratherapeutic doses 1
• Dose-dependent extrapyramidal symptoms - Though significantly less than typical antipsychotics 9

Critical Monitoring Points:

• Renal function is crucial - Amisulpride undergoes active renal secretion with 58% excreted unchanged in urine 1
• In severe renal impairment (eGFR <30 mL/min/1.73 m²), AUC doubles 1
• Supratherapeutic exposure risk (>600 ng/mL) increases with reduced renal function and higher daily doses 10
• Therapeutic drug monitoring is recommended, with target range typically below 600 ng/mL 10, 11

Switching Strategy:

When switching from other antipsychotics, use gradual cross-tapering over 4 weeks rather than abrupt cessation, maintaining concurrent treatments (anticholinergics, antiparkinsonian agents) until effective amisulpride dose is reached 8